EP2023989A1 — Dispensing device
Assigned to Glaxo Group Ltd · Expires 2009-02-18 · 17y expired
What this patent protects
A dispensing device for dispensing a number of doses of medication to a patient, comprising a dispensing mechanism (104, 105) for dispensing the medication by actuation of the dispensing mechanism from a non-dispensing position to a dispensing position, a dose counter (120) for…
USPTO Abstract
A dispensing device for dispensing a number of doses of medication to a patient, comprising a dispensing mechanism (104, 105) for dispensing the medication by actuation of the dispensing mechanism from a non-dispensing position to a dispensing position, a dose counter (120) for counting the number of doses dispensed by said device, a first battery-less arrangement (111, 112, 113) for providing power to said dose counter in response to the actuation of said dispensing mechanism, and an electronic display (108) for displaying a dose indication, characterised in that the device includes a second battery-less arrangement (109) for providing power to said electronic display when said dispensing mechanism is in said non-dispensing position.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.